1. Home
  2. ECOR vs BHM Comparison

ECOR vs BHM Comparison

Compare ECOR & BHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo electroCore Inc.

ECOR

electroCore Inc.

HOLD

Current Price

$6.25

Market Cap

50.0M

Sector

Health Care

ML Signal

HOLD

Logo Bluerock Homes Trust Inc.

BHM

Bluerock Homes Trust Inc.

HOLD

Current Price

$10.75

Market Cap

40.6M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECOR
BHM
Founded
2005
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
50.0M
40.6M
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
ECOR
BHM
Price
$6.25
$10.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$18.00
$15.00
AVG Volume (30 Days)
67.0K
9.7K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
4.44%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$32,032,000.00
$68,734,000.00
Revenue This Year
$33.60
N/A
Revenue Next Year
$30.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
27.20
36.88
52 Week Low
$4.16
$8.05
52 Week High
$8.55
$14.81

Technical Indicators

Market Signals
Indicator
ECOR
BHM
Relative Strength Index (RSI) 49.40 51.33
Support Level $4.65 $10.90
Resistance Level $6.94 $12.11
Average True Range (ATR) 0.65 0.71
MACD 0.04 -0.07
Stochastic Oscillator 46.45 37.39

Price Performance

Historical Comparison
ECOR
BHM

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The company has two reportable segments, consisting of Residential Communities, which derives maximum revenue; and Scattered Single-family homes.

Share on Social Networks: